Ciprofloxacin hydrochloride

DRUG3 trials

Sponsors

Fundacio Hospital Universitari Vall D’Hebron Institut De Recerca, National Institute of Allergy and Infectious Diseases (NIAID), Johns Hopkins University

Conditions

Acute bacterial prostatitisHIV InfectionsMycobacterium Avium-intracellulare InfectionProstate Infections

Phase 2

A Phase II/III Trial of Rifampin, Ciprofloxacin, Clofazimine, Ethambutol, and Amikacin in the Treatment of Disseminated Mycobacterium Avium Infection in HIV-Infected Individuals.

CompletedNCT00000641

National Institute of Allergy and Infectious Diseases (NIAID)HIV Infections, Mycobacterium Avium-intracellulare Infection

End: 1994-12-31Target: 90Updated: 2021-11-03

Phase 4

Impact of Antibiotic Treatment on Prostate-Specific Antigen (PSA) Variability

TerminatedNCT00596453

Johns Hopkins UniversityProstate Infections

Start: 2008-01-31End: 2011-06-30Updated: 2017-01-23

Clinical Efficacy of oral Fosfomycin Trometamol and Cefixime in the Treatment of Acute Bacterial Prostatitis (CEFOSPROST): a comparative, randomized, open, multicenter trial.

RecruitingCTIS2024-513465-39-00

Fundacio Hospital Universitari Vall D’Hebron Institut De RecercaAcute bacterial prostatitis

Start: 2024-12-04Target: 276Updated: 2025-11-28